Top Key Companies for IVD Infectious Diseases Market: Cepheid, Orasure, Hologic, Qiagen, Bio-Rad Laboratories, Sysmex, Siemens Healthcare, Danaher, Gen-Probe, Quidel, Roche Diagnostics, Abbott, BD, BioMerieux.
Global IVD Infectious Diseases Market Research Report: 2026-2035 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global IVD Infectious Diseases Market Overview And Scope:
The Global IVD Infectious Diseases Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of IVD Infectious Diseases utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global IVD Infectious Diseases Market Segmentation
By Type, IVD Infectious Diseases market has been segmented into:
Immunoassay
Molecular Diagnostics
Microbiology
Others
By Application, IVD Infectious Diseases market has been segmented into:
MRSA
Streptococcus
Clostridium Difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
Covid-19
Others
Regional Analysis of IVD Infectious Diseases Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of IVD Infectious Diseases Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The IVD Infectious Diseases market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the IVD Infectious Diseases market.
Top Key Companies Covered in IVD Infectious Diseases market are:
Cepheid
Orasure
Hologic
Qiagen
Bio-Rad Laboratories
Sysmex
Siemens Healthcare
Danaher
Gen-Probe
Quidel
Roche Diagnostics
Abbott
BD
BioMerieux
Key Questions answered in the IVD Infectious Diseases Market Report:
1. What is the expected IVD Infectious Diseases Market size during the forecast period, 2026-2035?
2. Which region is the largest market for the IVD Infectious Diseases Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the IVD Infectious Diseases Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the IVD Infectious Diseases Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key IVD Infectious Diseases companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the IVD Infectious Diseases Markets?
7. How is the funding and investment landscape in the IVD Infectious Diseases Market?
8. Which are the leading consortiums and associations in the IVD Infectious Diseases Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: IVD Infectious Diseases Market by Type
5.1 IVD Infectious Diseases Market Overview Snapshot and Growth Engine
5.2 IVD Infectious Diseases Market Overview
5.3 Immunoassay
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay: Geographic Segmentation
5.4 Molecular Diagnostics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Molecular Diagnostics: Geographic Segmentation
5.5 Microbiology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Microbiology: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: IVD Infectious Diseases Market by Application
6.1 IVD Infectious Diseases Market Overview Snapshot and Growth Engine
6.2 IVD Infectious Diseases Market Overview
6.3 MRSA
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 MRSA: Geographic Segmentation
6.4 Streptococcus
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Streptococcus: Geographic Segmentation
6.5 Clostridium Difficile
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clostridium Difficile: Geographic Segmentation
6.6 VRE
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 VRE: Geographic Segmentation
6.7 CRE
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 CRE: Geographic Segmentation
6.8 Respiratory Virus
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2026-2035F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Respiratory Virus: Geographic Segmentation
6.9 Candida
6.9.1 Introduction and Market Overview
6.9.2 Historic and Forecasted Market Size (2026-2035F)
6.9.3 Key Market Trends, Growth Factors and Opportunities
6.9.4 Candida: Geographic Segmentation
6.10 TB and Drug-resistant TB
6.10.1 Introduction and Market Overview
6.10.2 Historic and Forecasted Market Size (2026-2035F)
6.10.3 Key Market Trends, Growth Factors and Opportunities
6.10.4 TB and Drug-resistant TB: Geographic Segmentation
6.11 Gastro-intestinal Panel Testing
6.11.1 Introduction and Market Overview
6.11.2 Historic and Forecasted Market Size (2026-2035F)
6.11.3 Key Market Trends, Growth Factors and Opportunities
6.11.4 Gastro-intestinal Panel Testing: Geographic Segmentation
6.12 Chlamydia
6.12.1 Introduction and Market Overview
6.12.2 Historic and Forecasted Market Size (2026-2035F)
6.12.3 Key Market Trends, Growth Factors and Opportunities
6.12.4 Chlamydia: Geographic Segmentation
6.13 Gonorrhea
6.13.1 Introduction and Market Overview
6.13.2 Historic and Forecasted Market Size (2026-2035F)
6.13.3 Key Market Trends, Growth Factors and Opportunities
6.13.4 Gonorrhea: Geographic Segmentation
6.14 HPV
6.14.1 Introduction and Market Overview
6.14.2 Historic and Forecasted Market Size (2026-2035F)
6.14.3 Key Market Trends, Growth Factors and Opportunities
6.14.4 HPV: Geographic Segmentation
6.15 HIV
6.15.1 Introduction and Market Overview
6.15.2 Historic and Forecasted Market Size (2026-2035F)
6.15.3 Key Market Trends, Growth Factors and Opportunities
6.15.4 HIV: Geographic Segmentation
6.16 Hepatitis C
6.16.1 Introduction and Market Overview
6.16.2 Historic and Forecasted Market Size (2026-2035F)
6.16.3 Key Market Trends, Growth Factors and Opportunities
6.16.4 Hepatitis C: Geographic Segmentation
6.17 Hepatitis B
6.17.1 Introduction and Market Overview
6.17.2 Historic and Forecasted Market Size (2026-2035F)
6.17.3 Key Market Trends, Growth Factors and Opportunities
6.17.4 Hepatitis B: Geographic Segmentation
6.18 Covid-19
6.18.1 Introduction and Market Overview
6.18.2 Historic and Forecasted Market Size (2026-2035F)
6.18.3 Key Market Trends, Growth Factors and Opportunities
6.18.4 Covid-19: Geographic Segmentation
6.19 Others
6.19.1 Introduction and Market Overview
6.19.2 Historic and Forecasted Market Size (2026-2035F)
6.19.3 Key Market Trends, Growth Factors and Opportunities
6.19.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 IVD Infectious Diseases Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 IVD Infectious Diseases Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 IVD Infectious Diseases Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CEPHEID
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ORASURE
7.4 HOLOGIC
7.5 QIAGEN
7.6 BIO-RAD LABORATORIES
7.7 SYSMEX
7.8 SIEMENS HEALTHCARE
7.9 DANAHER
7.10 GEN-PROBE
7.11 QUIDEL
7.12 ROCHE DIAGNOSTICS
7.13 ABBOTT
7.14 BD
7.15 BIOMERIEUX
Chapter 8: Global IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Immunoassay
8.2.2 Molecular Diagnostics
8.2.3 Microbiology
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 MRSA
8.3.2 Streptococcus
8.3.3 Clostridium Difficile
8.3.4 VRE
8.3.5 CRE
8.3.6 Respiratory Virus
8.3.7 Candida
8.3.8 TB and Drug-resistant TB
8.3.9 Gastro-intestinal Panel Testing
8.3.10 Chlamydia
8.3.11 Gonorrhea
8.3.12 HPV
8.3.13 HIV
8.3.14 Hepatitis C
8.3.15 Hepatitis B
8.3.16 Covid-19
8.3.17 Others
Chapter 9: North America IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Immunoassay
9.4.2 Molecular Diagnostics
9.4.3 Microbiology
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 MRSA
9.5.2 Streptococcus
9.5.3 Clostridium Difficile
9.5.4 VRE
9.5.5 CRE
9.5.6 Respiratory Virus
9.5.7 Candida
9.5.8 TB and Drug-resistant TB
9.5.9 Gastro-intestinal Panel Testing
9.5.10 Chlamydia
9.5.11 Gonorrhea
9.5.12 HPV
9.5.13 HIV
9.5.14 Hepatitis C
9.5.15 Hepatitis B
9.5.16 Covid-19
9.5.17 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Immunoassay
10.4.2 Molecular Diagnostics
10.4.3 Microbiology
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 MRSA
10.5.2 Streptococcus
10.5.3 Clostridium Difficile
10.5.4 VRE
10.5.5 CRE
10.5.6 Respiratory Virus
10.5.7 Candida
10.5.8 TB and Drug-resistant TB
10.5.9 Gastro-intestinal Panel Testing
10.5.10 Chlamydia
10.5.11 Gonorrhea
10.5.12 HPV
10.5.13 HIV
10.5.14 Hepatitis C
10.5.15 Hepatitis B
10.5.16 Covid-19
10.5.17 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Immunoassay
11.4.2 Molecular Diagnostics
11.4.3 Microbiology
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 MRSA
11.5.2 Streptococcus
11.5.3 Clostridium Difficile
11.5.4 VRE
11.5.5 CRE
11.5.6 Respiratory Virus
11.5.7 Candida
11.5.8 TB and Drug-resistant TB
11.5.9 Gastro-intestinal Panel Testing
11.5.10 Chlamydia
11.5.11 Gonorrhea
11.5.12 HPV
11.5.13 HIV
11.5.14 Hepatitis C
11.5.15 Hepatitis B
11.5.16 Covid-19
11.5.17 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Immunoassay
12.4.2 Molecular Diagnostics
12.4.3 Microbiology
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 MRSA
12.5.2 Streptococcus
12.5.3 Clostridium Difficile
12.5.4 VRE
12.5.5 CRE
12.5.6 Respiratory Virus
12.5.7 Candida
12.5.8 TB and Drug-resistant TB
12.5.9 Gastro-intestinal Panel Testing
12.5.10 Chlamydia
12.5.11 Gonorrhea
12.5.12 HPV
12.5.13 HIV
12.5.14 Hepatitis C
12.5.15 Hepatitis B
12.5.16 Covid-19
12.5.17 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Immunoassay
13.4.2 Molecular Diagnostics
13.4.3 Microbiology
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 MRSA
13.5.2 Streptococcus
13.5.3 Clostridium Difficile
13.5.4 VRE
13.5.5 CRE
13.5.6 Respiratory Virus
13.5.7 Candida
13.5.8 TB and Drug-resistant TB
13.5.9 Gastro-intestinal Panel Testing
13.5.10 Chlamydia
13.5.11 Gonorrhea
13.5.12 HPV
13.5.13 HIV
13.5.14 Hepatitis C
13.5.15 Hepatitis B
13.5.16 Covid-19
13.5.17 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America IVD Infectious Diseases Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Immunoassay
14.4.2 Molecular Diagnostics
14.4.3 Microbiology
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 MRSA
14.5.2 Streptococcus
14.5.3 Clostridium Difficile
14.5.4 VRE
14.5.5 CRE
14.5.6 Respiratory Virus
14.5.7 Candida
14.5.8 TB and Drug-resistant TB
14.5.9 Gastro-intestinal Panel Testing
14.5.10 Chlamydia
14.5.11 Gonorrhea
14.5.12 HPV
14.5.13 HIV
14.5.14 Hepatitis C
14.5.15 Hepatitis B
14.5.16 Covid-19
14.5.17 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
IVD Infectious Diseases Scope:
|
Report Data
|
IVD Infectious Diseases Market
|
|
IVD Infectious Diseases Market Size in 2025
|
USD XX million
|
|
IVD Infectious Diseases CAGR 2025 - 2032
|
XX%
|
|
IVD Infectious Diseases Base Year
|
2024
|
|
IVD Infectious Diseases Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Cepheid, Orasure, Hologic, Qiagen, Bio-Rad Laboratories, Sysmex, Siemens Healthcare, Danaher, Gen-Probe, Quidel, Roche Diagnostics, Abbott, BD, BioMerieux.
|
|
Key Segments
|
By Type
Immunoassay
Molecular Diagnostics
Microbiology
Others
By Applications
MRSA
Streptococcus
Clostridium Difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
Covid-19
Others
|
